BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 23488524)

  • 1. Global consensus statement on menopausal hormone therapy.
    de Villiers TJ; Gass ML; Haines CJ; Hall JE; Lobo RA; Pierroz DD; Rees M
    Climacteric; 2013 Apr; 16(2):203-4. PubMed ID: 23488524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2017 hormone therapy position statement of The North American Menopause Society.
    Menopause; 2018 Nov; 25(11):1362-1387. PubMed ID: 30358733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society.
    Gambacciani M; Biglia N; Cagnacci A; Caruso S; Cicinelli E; DE Leo V; DI Carlo C; Farris M; Gambera A; Guaschino S; Lanzone A; Paoletti AM; Russo N; Vicariotto F; Villa P; Volpe A;
    Minerva Ginecol; 2018 Feb; 70(1):27-34. PubMed ID: 28975776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2017 hormone therapy position statement of The North American Menopause Society.
    The NAMS 2017 Hormone Therapy Position Statement Advisory Panel
    Menopause; 2017 Jul; 24(7):728-753. PubMed ID: 28650869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. South African Menopause Society Council consensus statement on menopausal hormone therapy.
    de Villiers TJ;
    S Afr Med J; 2004 Sep; 94(9):760-2. PubMed ID: 15487841
    [No Abstract]   [Full Text] [Related]  

  • 7. Estrogen and progestogen therapy in postmenopausal women.
    Practice Committee of the American Society for Reproductive Medicine
    Fertil Steril; 2006 Nov; 86(5 Suppl 1):S75-88. PubMed ID: 17055850
    [No Abstract]   [Full Text] [Related]  

  • 8. Revised global consensus statement on menopausal hormone therapy.
    de Villiers TJ; Hall JE; Pinkerton JV; PĂ©rez SC; Rees M; Yang C; Pierroz DD
    Maturitas; 2016 Sep; 91():153-5. PubMed ID: 27389038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and the menopause. Australian Menopause Society.
    MacLennan AH
    Med J Aust; 1991 Jul; 155(1):43-4. PubMed ID: 2067437
    [No Abstract]   [Full Text] [Related]  

  • 10. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.
    de Villiers TJ; Pines A; Panay N; Gambacciani M; Archer DF; Baber RJ; Davis SR; Gompel AA; Henderson VW; Langer R; Lobo RA; Plu-Bureau G; Sturdee DW;
    Climacteric; 2013 Jun; 16(3):316-37. PubMed ID: 23672656
    [No Abstract]   [Full Text] [Related]  

  • 11. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society.
    Menopause; 2000; 7(2):76-86. PubMed ID: 10746889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy and breast cancer: the press-release version of WHI study data.
    Pines A
    Climacteric; 2013 Apr; 16(2):222-5. PubMed ID: 23488525
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rationale for low-dose hormonal therapy.
    Lobo RA
    Endocrine; 2004 Aug; 24(3):217-21. PubMed ID: 15542888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2010 Mar; 17(2):242-55. PubMed ID: 20154637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
    [No Abstract]   [Full Text] [Related]  

  • 18. EMAS position statement: Managing the menopause in the context of coronary heart disease.
    Schenck-Gustafsson K; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Tremollieres F; Vujovic S; Rozenberg S; Rees M;
    Maturitas; 2011 Jan; 68(1):94-7. PubMed ID: 21156341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormone replacement therapy and breast cancer--any news?].
    Holli K
    Duodecim; 1999; 115(2):101-2. PubMed ID: 11830839
    [No Abstract]   [Full Text] [Related]  

  • 20. A practical guide to prescribing estrogen replacement therapy.
    Corson SL
    Int J Fertil Menopausal Stud; 1995; 40(5):229-47. PubMed ID: 8556028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.